Focusing on microRNA drug development and PDEV delivery system

Golden Biotech, founded by Professor Yangchao Chen's team from the Faculty of Medicine at CUHK, is a company based at Hong Kong Science Park and dedicated to the R&D of innovative RNA‑based drugs, utilizing extracellular vesicles as a delivery system. The company’s proprietary PDEV platform is a natural, biocompatible nanocarrier enabling targeted and sustained delivery. Its therapeutic pipeline covers lung cancer, COPD, rhinitis, eye diseases, and hair loss. In parallel, the same PDEV technology is applied to skincare products and intimate care gels.